B Leyland-Jones Selected Research

B Leyland-Jones Research Topics

13	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2001
7	Neoplasms (Cancer) 11/2012 - 01/2001
4	Disease Progression 04/2015 - 03/2001
1	Triple Negative Breast Neoplasms 11/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2008
1	Colorectal Neoplasms (Colorectal Cancer) 10/2007
1	Colonic Neoplasms (Colon Cancer) 10/2007
1	Genomic Instability 01/2004
1	Ovarian Neoplasms (Ovarian Cancer) 01/2004

6	Trastuzumab (Herceptin)FDA Link 06/2008 - 01/2001
3	human ERBB2 proteinIBA 11/2012 - 06/2008
3	Epidermal Growth Factor (EGF)IBA 12/2001 - 01/2001
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2010
2	Estrogen ReceptorsIBA 01/2018 - 11/2017
2	HematinicsIBA 04/2015 - 03/2012
2	Monoclonal AntibodiesIBA 03/2001 - 01/2001
1	Circulating Tumor DNAIBA 11/2017
1	Biosimilar PharmaceuticalsIBA 04/2015
1	Hormones (Hormone)IBA 11/2012
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 03/2012
1	ParaffinIBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Formaldehyde (Formol)FDA Link 11/2011
1	Phenobarbital (Luminal)FDA Link 03/2010
1	Estrogen Receptor alphaIBA 03/2010
1	Gefitinib (Iressa)FDA Link 07/2008
1	Tyrosine Kinase InhibitorsIBA 07/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2008
1	C 1311IBA 10/2007
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2007
1	Protein Isoforms (Isoforms)IBA 07/2007
1	xanafideIBA 07/2007
1	RNA (Ribonucleic Acid)IBA 01/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2004
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2003
1	Antineoplastic Agents (Antineoplastics)IBA 12/2003
1	Insulin-Like Growth Factor Binding Protein 3IBA 12/2003
1	Growth Factor ReceptorsIBA 03/2001
1	Fluorouracil (Carac)FDA LinkGeneric 01/2001
1	Capecitabine (Xeloda)FDA Link 01/2001
1	Taxoids (Taxanes)IBA 01/2001

5	Therapeutics 01/2018 - 01/2001
5	Drug Therapy (Chemotherapy) 04/2015 - 03/2001